InsidersTradesSigma
Follow the Kaleido Biosciences, Inc. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Operating in the Health Care sector, Kaleido Biosciences, Inc. has recorded 2 reports. Market capitalisation: €4k. The latest transaction was reported on 2 March 2022 (Retenue fiscale). Among the most active insiders: van Hylckama Vlieg Johan. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Kaleido Biosciences, Inc. 是一家专注于开发基于微生物组疗法以治疗各种疾病的公司。它强调医疗保健和制药领域的创新。